Alireza Faridar, MD
Dr. Faridar was trained at the Tehran University of Medical Sciences, the most prestigious medical schools in Iran. After graduating from medical school, he received research training at Heidelberg University, Germany, and came to the United States in 2010 to continue his research fellowships at Mayo Clinic Rochester, and UCSF. His effort as a post-doctoral research scholar in neuroscience department at UCSF culminated in developing a new blood biomarker in Autism. In 2013, he joined the Neurology Residency Program at the Houston Methodist Neurological Institute. During his residency and subsequent fellowship, he worked with Dr. Appel and Dr. Masdeu as his mentors who are the two world leaders in the field of neurodegeneration. He is particularly interested in evaluating the role of adaptive immune system in Alzheimer disease and its potential as a novel therapeutic target.